Inverness buys diagnostics firm Wampole for $70 million
This article was originally published in Clinica
Executive Summary
Inverness Medical Innovations is buying Wampole Laboratories from pharmaceutical company MedPointe for $70m in a move that will give it a "formidable presence in point-of-care diagnostics", including a strong line of point-of-care immunoassays.